| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 5 | +60.2K | 34.7% | $1.47 | +$88.5K |
| Sells | 4 | -113K | 65.3% | $0.96 | -$108K |
| Net | +1 | -53.2K | -30.6% | -$19.9K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| James C. Czirr | 10%+ Owner | $22.7M | -$11.3K | -0.05% | Apr 22, 2024 |
| Richard E. Uihlein | Director, 10%+ Owner | $12.7M | Jan 23, 2025 | ||
| 10X Fund, L.P. | 10%+ Owner | $10.6M | Dec 31, 2022 | ||
| Joel Lewis | President and CEO, Director | $1.41M | -$46.2K | -3.18% | Mar 3, 2025 |
| Kevin D. Freeman | Director | $116K | +$44.5K | +62.1% | Jan 23, 2025 |
| Khurram Jamil | Chief Medical Officer | $92.8K | -$12K | -11.5% | Jan 23, 2025 |
| Jack W. Callicutt | Chief Financial Officer | $76.4K | -$35.5K | -31.7% | Jan 23, 2025 |
| Pol F. Boudes | Chief Medical Officer | $71.4K | Jan 24, 2024 | ||
| Kary Eldred | Director | $55.8K | +$13.3K | +31.3% | Jan 23, 2025 |
| Richard A. Zordani Jr. | Director | $36K | +$19.7K | +121% | Jan 23, 2025 |
| Harold H. Shlevin | Director | $17.6K | +$7.54K | +74.7% | Jan 23, 2025 |
| Benjamin Sr Carson | Director | Jan 23, 2025 | |||
| Gilbert S. Omenn | Director | Jan 23, 2025 | |||
| Gilbert F. Amelio | Director | Jan 24, 2024 | |||
| Marc Rubin | Director | Jan 23, 2025 | |||
| Elissa J. Schwartz | Director | Jan 23, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|